Central Pacific Bank - Trust Division’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$882K Hold
9,925
– – 0.09% 204
2026
Q2
$854K Hold
9,925
– – 0.09% 221
2026
Q1
$897K Buy
9,925
+100
+1% +$9.18K 0.11% 187
2025
Q4
$883K Sell
9,825
-5,650
-37% -$536K 0.11% 194
2025
Q3
$1.52M Buy
15,475
+300
+2% +$29.7K 0.18% 126
2025
Q2
$1.38M Buy
15,175
+850
+6% +$82.2K 0.18% 128
2025
Q1
$1.62M Sell
14,325
-200
-1% -$21.4K 0.22% 117
2024
Q4
$1.53M Buy
14,525
+1,000
+7% +$107K 0.2% 123
2024
Q3
$1.46M Sell
13,525
-915
-6% -$99.9K 0.18% 139
2024
Q2
$1.57M Hold
14,440
– – 0.19% 128
2024
Q1
$1.87M Buy
+14,440
New +$1.8M 0.23% 111

Other funds holding ZBH

Central Pacific Bank - Trust Division's ZBH Position: Q3 2026 in Review

Central Pacific Bank - Trust Division held its Zimmer Biomet (ZBH) position steady in Q3 2026 at 9,925 shares worth $882K. The position accounts for 0.09% of the portfolio, ranked #204.

Central Pacific Bank - Trust Division first reported a position in ZBH in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.87M in Q1 2024. 27 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Central Pacific Bank - Trust Division held 9,925 shares of Zimmer Biomet worth $882K as of Q3 2026.
  • Central Pacific Bank - Trust Division left its Zimmer Biomet share count unchanged in Q3 2026.
  • Zimmer Biomet made up 0.09% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #204 holding.
  • Central Pacific Bank - Trust Division first reported a position in Zimmer Biomet in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's Zimmer Biomet position peaked at $1.87M in Q1 2024.
  • 27 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.